230 related articles for article (PubMed ID: 21625978)
41. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter.
Reeves MB; Sinclair JH
J Gen Virol; 2010 Mar; 91(Pt 3):599-604. PubMed ID: 19906945
[TBL] [Abstract][Full Text] [Related]
42. In vivo expression of human cytomegalovirus (HCMV) microRNAs during latency.
Meshesha MK; Bentwich Z; Solomon SA; Avni YS
Gene; 2016 Jan; 575(1):101-7. PubMed ID: 26302752
[TBL] [Abstract][Full Text] [Related]
43. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.
Kondo K; Xu J; Mocarski ES
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11137-42. PubMed ID: 8855322
[TBL] [Abstract][Full Text] [Related]
44. A Viral Pilot for HCMV Navigation?
Adler B
Viruses; 2015 Jul; 7(7):3857-62. PubMed ID: 26184287
[TBL] [Abstract][Full Text] [Related]
45. Tissue macrophages are infected by human cytomegalovirus in vivo.
Sinzger C; Plachter B; Grefte A; The TH; Jahn G
J Infect Dis; 1996 Jan; 173(1):240-5. PubMed ID: 8537667
[TBL] [Abstract][Full Text] [Related]
46. Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
Shnayder M; Nachshon A; Krishna B; Poole E; Boshkov A; Binyamin A; Maza I; Sinclair J; Schwartz M; Stern-Ginossar N
mBio; 2018 Mar; 9(2):. PubMed ID: 29535194
[TBL] [Abstract][Full Text] [Related]
47. Characterization of specific antibodies against cytomegalovirus (CMV)-encoded interleukin 10 produced by 28% of CMV-seropositive blood donors.
de Lemos Rieper C; Galle P; Pedersen BK; Hansen MB
J Gen Virol; 2011 Jul; 92(Pt 7):1508-1518. PubMed ID: 21402594
[TBL] [Abstract][Full Text] [Related]
48. A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody.
Re MC; Landini MP; Coppolecchia P; Furlini G; La Placa M
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2507-11. PubMed ID: 2997381
[TBL] [Abstract][Full Text] [Related]
49. Comparison of PCRs for IE-1 and gB genes with ELISA of IgM antibodies for diagnosis of human cytomegalovirus disease.
Mewara A; Mishra B; Ratho RK; Kumar P
Acta Virol; 2010; 54(4):315-6. PubMed ID: 21175258
[No Abstract] [Full Text] [Related]
50. Expression in insect cells and immune reactivity of a 28K tegument protein of human cytomegalovirus.
Giugni TD; Churchill MA; Pande H; Campo K; Guha M; Zaia JA
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2367-74. PubMed ID: 1328492
[TBL] [Abstract][Full Text] [Related]
51. The Transcriptome of Latent Human Cytomegalovirus.
Schwartz M; Stern-Ginossar N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867313
[TBL] [Abstract][Full Text] [Related]
52. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.
Jenkins C; Garcia W; Godwin MJ; Spencer JV; Stern JL; Abendroth A; Slobedman B
J Virol; 2008 Apr; 82(7):3736-50. PubMed ID: 18216121
[TBL] [Abstract][Full Text] [Related]
53. The Role of the Human Cytomegalovirus
Mlera L; Moy M; Maness K; Tran LN; Goodrum FD
Viruses; 2020 Jul; 12(7):. PubMed ID: 32630219
[TBL] [Abstract][Full Text] [Related]
54. Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors.
Falk JJ; Winkelmann M; Stöhr D; Alt M; Schrezenmeier H; Krawczyk A; Lotfi R; Sinzger C
J Infect Dis; 2018 Aug; 218(6):876-885. PubMed ID: 29684155
[TBL] [Abstract][Full Text] [Related]
55. Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.
Heo J; Dogra P; Masi TJ; Pitt EA; de Kruijf P; Smit MJ; Sparer TE
J Immunol; 2015 Jul; 195(1):227-36. PubMed ID: 25987741
[TBL] [Abstract][Full Text] [Related]
56. [The detection of the antibodies of human cytomegalovirus in the sera of patients with coronary heart disease].
Li B; Xu C; Wang Q
Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):741-3. PubMed ID: 9592340
[TBL] [Abstract][Full Text] [Related]
57. The Human Cytomegalovirus Latency-Associated Gene Product Latency Unique Natural Antigen Regulates Latent Gene Expression.
Poole E; Lau J; Groves I; Roche K; Murphy E; Carlan da Silva M; Reeves M; Sinclair J
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766281
[TBL] [Abstract][Full Text] [Related]
58. Human immune responses to major human cytomegalovirus glycoprotein complexes.
Liu YN; Kari B; Gehrz RC
J Virol; 1988 Mar; 62(3):1066-70. PubMed ID: 2828655
[TBL] [Abstract][Full Text] [Related]
59. Latency and reactivation of human cytomegalovirus.
Sinclair J; Sissons P
J Gen Virol; 2006 Jul; 87(Pt 7):1763-1779. PubMed ID: 16760381
[TBL] [Abstract][Full Text] [Related]
60. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.
Gerna G; Sarasini A; Patrone M; Percivalle E; Fiorina L; Campanini G; Gallina A; Baldanti F; Revello MG
J Gen Virol; 2008 Apr; 89(Pt 4):853-865. PubMed ID: 18343825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
